Do the effects of APOE- E4 on cognitive function and decline depend upon vitamin status? Macarthur studies of successful aging

Journal of Nutrition, Health and Aging

Volumn 15, Issue 3, 2011, Pages 196-201

  Brown, B ^a   Huang, M H ^b   Karlamangla, A ^b   Seeman, T ^b   Kado, D ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

APOE; B vitamins; cognition; cognitive decline; homocysteine

Indexed keywords

APOLIPOPROTEIN E4; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; VITAMIN B GROUP; VITAMIN B COMPLEX;

AGE; AGED; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONCEPT FORMATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELAYED RECOGNITION SPAN TEST; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GENE FREQUENCY; GENOTYPE; GERIATRIC DISORDER; HUMAN; LANGUAGE ABILITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SEX DIFFERENCE; SPATIAL MEMORY; VERBAL MEMORY; VITAMIN BLOOD LEVEL; AGING; BLOOD; COHORT ANALYSIS; GENETICS; NUTRIGENOMICS; NUTRITIONAL STATUS; PHYSIOLOGY; UNITED STATES;

AGED; AGING; APOLIPOPROTEIN E4; COGNITION; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; LONGITUDINAL STUDIES; MALE; NUTRIGENOMICS; NUTRITIONAL STATUS; UNITED STATES; VITAMIN B COMPLEX;

EID: 79954421887     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-010-0277-5     Document Type: Article

References (50)

1. L. Bertram, et al. 2007 Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat Genet 39 1 17 23 17192785 10.1038/ng1934 1:CAS:528:DC%2BD28XhtlGktLjM (Pubitemid 46026496)
2. E. Corder A.M. Saunders W.J. Strittmatter D.E. Schmechel P. Gaskell G.W. Small A.D. Roses J.L. Haines M.A. Pericak-Vance 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 921 923 8346443 10.1126/science.8346443 1:CAS:528: DyaK3sXmtVWjur8%3D (Pubitemid 23275809)
3. L. Bertram R.E. Tanzi 2008 Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat Rev Neurosci 9 10 768 778 18802446 10.1038/nrn2494 1:CAS:528:DC%2BD1cXhtFeit7fL
4. L. Migliore F. Coppede 2009 Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases Mutat Res 667 1-2 82 97 19026668 1:CAS:528:DC%2BD1MXnsl2iu7o%3D
5. M. Kivipelto, et al. 2008 Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study J Cell Mol Med 12 6B 2762 2771 18318693 10.1111/j.1582-4934.2008.00296.x 1:CAS:528:DC%2BD1MXhvVGmsbw%3D
6. R. Clarke, et al. 1998 Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease Arch Neurol 55 11 1449 1455 9823829 10.1001/archneur.55.11.1449 1:STN:280:DyaK1M%2FjvFCgtw%3D%3D (Pubitemid 28525506)
7. A. McCaddon, et al. 2002 Functional vitamin B12 deficiency and Alzheimer disease Neurology 58 9 1395 1399 12011287 1:CAS:528:DC%2BD38Xktlyks70%3D (Pubitemid 34507168)
8. S. Seshadri, et al. 2002 Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease N Engl J Med 346 7 476 483 11844848 10.1056/NEJMoa011613 1:CAS:528:DC%2BD38XhtFCktrw%3D (Pubitemid 34441738)
9. D. Kado A.S. Karlamangla M.-H. Huang A. Troen J.W. Rowe J. Selhub T.E. Seeman 2005 Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: Macarthur studies of successful aging The American Journal of Medicine 118 2 161 167 15694902 10.1016/j.amjmed.2004.08.019 1:CAS:528:DC%2BD2MXhtVyisLs%3D (Pubitemid 40202865)
10. J.F. Toole, et al. 2004 Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 291 5 565 575 14762035 10.1001/jama.291.5.565 1:CAS:528: DC%2BD2cXhtVylsL4%3D (Pubitemid 38500310)
11. E. Lonn 2008 Homocysteine-lowering B vitamin therapy in cardiovascular prevention-wrong again? JAMA 299 17 2086 2087 18460669 10.1001/jama.299.17.2086 1:CAS:528:DC%2BD1cXlslalsL8%3D (Pubitemid 351656591)
12. C.M. Albert, et al. 2008 Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial JAMA 299 17 2027 2036 18460663 10.1001/jama.299.17.2027 1:CAS:528:DC%2BD1cXlslanurs%3D (Pubitemid 351656584)
13. D. Bunce M. Kivipelto A. Wahlin 2004 Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older Neuropsychology 18 2 362 370 15099158 10.1037/0894-4105.18.2.362 (Pubitemid 38520340)
14. G. Anello, et al. 2004 Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease Neuroreport 15 5 859 861 15073531 10.1097/00001756-200404090-00025 1:CAS:528:DC%2BD2cXjvFKrsrc%3D (Pubitemid 38453474)
15. D. Bunce M. Kivipelto A. Wahlin 2005 Apolipoprotein E, B vitamins, and cognitive function in older adults J Gerontol B Psychol Sci Soc Sci 60 1 41 48
16. D. Bunce M. Kivipelto A. Wahlin 2005 Apolipoprotein E, B vitamins, and cognitive function in older adults Journal of Gerontology: Psychological Sciences 60B 1 41 48
17. J.H. Schafer, et al. 2005 Homocysteine and cognitive function in a population-based study of older adults J Am Geriatr Soc 53 3 381 388 15743278 10.1111/j.1532-5415.2005.53153.x (Pubitemid 41623514)
18. M.F. Elias, et al. 2008 Homocysteine and cognitive performance: modification by the ApoE genotype Neurosci Lett 430 1 64 69 18023533 10.1016/j.neulet.2007.10.021 1:CAS:528:DC%2BD1cXivFWjsw%3D%3D
19. C. Dufouil, et al. 2003 Homocysteine, white matter hyperintensities, and cognition in healthy elderly people Ann Neurol 53 2 214 221 12557288 10.1002/ana.10440 1:CAS:528:DC%2BD3sXhs1Wltb0%3D (Pubitemid 36164003)
20. L.J. Podewils, et al. 2005 Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study Am J Epidemiol 161 7 639 651 15781953 10.1093/aje/kwi092 (Pubitemid 40411092)
21. T. Seeman M.-H. Huang P. Bretsky E. Crimmins L. Launer J.M. Guralnik 2005 Education and APOE-e4 in longitudinal cognitive decline: Macarthur studies of successful aging Journal of Gerontology: Psychological Sciences 60B 2 74 83
22. T.L. Huang, et al. 2005 Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4 Neurology 65 9 1409 1414 16275829 10.1212/01.wnl.0000183148.34197.2e 1:STN:280:DC%2BD2Mrps12lsA%3D%3D (Pubitemid 41552771)
23. D.M. Kado, et al. 2005 Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging Am J Med 118 2 161 167 15694902 10.1016/j.amjmed.2004.08.019 1:CAS:528:DC%2BD2MXhtVyisLs%3D (Pubitemid 40202865)
24. D.M. Kado, et al. 2002 Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging Am J Med 113 7 537 542 12459398 10.1016/S0002-9343(02)01269-X 1:CAS:528:DC%2BD38XovFGqtbk%3D (Pubitemid 35379907)
25. A. Araki Y. Sako 1987 Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection J Chromatogr 422 43 52 3437026 10.1016/0378-4347(87)80438-3 1:CAS:528:DyaL1cXjsVakuw%3D%3D (Pubitemid 17167357)
26. P.M. Ueland, et al. 1993 Total homocysteine in plasma or serum: methods and clinical applications Clin Chem 39 9 1764 1779 8375046 1:CAS:528: DyaK3sXms1Gmu7k%3D (Pubitemid 23277003)
27. T. Tamura L.E. Freeberg P.E. Cornwell 1990 Inhibition of EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron Clin Chem 36 11 1993 2122927 1:STN:280: DyaK3M%2FlsFelsg%3D%3D
28. V.M. Camp J. Chipponi B.A. Faraj 1983 Radioenzymatic assay for direct measurement of plasma pyridoxal 5â€-phosphate Clin Chem 29 4 642 644 6831691 1:CAS:528:DyaL3sXktVamtr8%3D (Pubitemid 13109699)
29. A.M. Saunders, et al. 1993 Association of apolipoprotein E allele epsilon 4 with lateonset familial and sporadic Alzheimer's disease Neurology 43 8 1467 1472 8350998 1:CAS:528:DyaK2cXhvVyksbc%3D (Pubitemid 23230526)
30. E.H. Corder, et al. 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 921 923 8346443 10.1126/science.8346443 1:CAS:528:DyaK3sXmtVWjur8%3D (Pubitemid 23275809)
31. E.J. Dubelaar, et al. 2004 ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus J Neuropathol Exp Neurol 63 2 159 169 14989602 1:CAS:528:DC%2BD2cXhvVWhsLg%3D (Pubitemid 38174781)
32. R.S. Wilson, et al. 1999 Cognitive activity in older persons from a geographically defined population J Gerontol B Psychol Sci Soc Sci 54 3 P155 P160 10363036 1:STN:280:DyaK1M3ptFaitw%3D%3D
33. M.X. Tang, et al. 1998 The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics JAMA 279 10 751 755 9508150 10.1001/jama.279.10.751 1:STN:280:DyaK1c7mslGktw%3D%3D (Pubitemid 28114999)
34. S.K. Inouye, et al. 1993 Cognitive performance in a high-functioning community-dwelling elderly population J Gerontol 48 4 M146 M151 8315227 1:STN:280:DyaK3szgtFekuw%3D%3D (Pubitemid 23199253)
35. Kaplan, E., H. Goodglass, and S. Weintraub, The Boston Naming Test and scoring booklet, in The assessment of aphasia and related disorders, H. Goodglass, Kaplan, E., Editor. 1983, Lea and Febiger: Philadelphia, Pennsylvania. p.
36. W.G. Rosen R.C. Mohs K.L. Davis 1984 A new rating scale for Alzheimer's disease Am J Psychiatry 141 11 1356 1364 6496779 1:STN:280: DyaL2M%2FksVeqtA%3D%3D
37. Wechsler, D., Wechsler Adult Intelligence Scale-Revised (WAIS-R) Manual. 1981, New York, New York: The Psychological Corporation.
38. S. Inouye M.S. Albert R. Mohs K. Sun L.F. Berkman 1993 Cognitive performance in a high-functioning community-dwelling elderly population Journal of Gerontology: Medical Sciences 48 4 M146 M151 1:STN:280:DyaK3szgtFekuw%3D%3D (Pubitemid 23199253)
39. P. Bretsky, et al. 2003 The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging Neurology 60 7 1077 1081 12682309 1:STN:280:DC%2BD3s7msFSisA%3D%3D (Pubitemid 36418763)
40. K.J. Rothman 1990 No adjustments are needed for multiple comparisons Epidemiology 1 1 43 46 2081237 10.1097/00001648-199001000-00010 1:STN:280:DyaK3M7otlShtA%3D%3D (Pubitemid 20255621)
41. M.N. Haan, et al. 1999 The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons JAMA 282 1 40 46 10404910 10.1001/jama.282.1.40 1:STN:280:DyaK1MzjtFOqtA%3D%3D (Pubitemid 29318931)
42. A.B. Graves, et al. 1999 Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status Neurology 53 7 1480 1487 10534255 1:STN:280:DC%2BD3c%2FgtFyhsA%3D%3D (Pubitemid 29491941)
43. G.J. Petot, et al. 2003 Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life Metabolism 52 3 279 281 12647263 10.1053/meta.2003.50066 1:CAS:528:DC%2BD3sXitlWgtLk%3D (Pubitemid 36401671)
44. P. Hu, et al. 2006 Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging J Gerontol A Biol Sci Med Sci 61 6 616 620 16799145
45. Kivipelto, M., et al., Apolipoprotein E epsilon4 Magnifies Lifestyle Risks for Dementia: A Population Based Study. J Cell Mol Med, 2008: p. 1-26.
46. K. Yaffe, et al. 2000 Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction Neurology 54 10 1949 1954 10822435 1:CAS:528:DC%2BD3cXktVOlurg%3D
47. M.N. Haan, et al. 1999 The Role of APOE'epsilon'4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons JAMA 282 1 40 46 10404910 10.1001/jama.282.1.40 1:STN:280:DyaK1MzjtFOqtA%3D%3D (Pubitemid 29318931)
48. R. Clarke, et al. 1998 Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch Neurol 55 11 1449 1455 9823829 10.1001/archneur.55.11.1449 1:STN:280:DyaK1M%2FjvFCgtw%3D%3D (Pubitemid 28525506)
49. A. McCaddon, et al. 1998 Total serum homocysteine in senile dementia of Alzheimer type Int J Geriatr Psychiatry 13 4 235 239 9646150 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8 1:STN:280:DyaK1czhtVWiug%3D%3D (Pubitemid 28194997)
50. L.A. Bazzano, et al. 2006 Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials JAMA 296 22 2720 2726 17164458 10.1001/jama.296.22.2720 1:CAS:528:DC%2BD28XhtlWrtrjE (Pubitemid 44917549)